A Myocardial Infarction During Intravenous Recombinant Tissue Plasminogen Activator Infusion for Evolving Ischemic

Sabine Fitzek1, Clemens Fitzek

  • 1Departments of *Neurology †Radiology and Neuroradiology, Asklepios Fachklinikum Brandenburg, Brandenburg, Germany.

The Neurologist
|September 17, 2015
PubMed
Abstract

Insights

Systemic thrombolysis with recombinant tissue-type plasminogen activator (rtPA) may cause embolic myocardial infarction (MI) by fragmenting cardiac thrombi. This rare complication highlights a serious risk associated with rtPA therapy.

Area of Science:

  • Cardiology
  • Neurology
  • Thrombolytic Therapy

Background:

  • Intracardiac thrombus formation increases stroke risk post-myocardial infarction (MI).
  • Recombinant tissue-type plasminogen activator (rtPA) is used for acute ischemic stroke and evolving myocardial infarction.

Observation:

  • A case of fatal myocardial infarction (MI) occurred immediately after initiating rtPA infusion for a middle cerebral artery stroke.
  • The patient was an 88-year-old woman.

Findings:

  • Systemic thrombolysis with rtPA is hypothesized to have caused fragmentation of an underlying cardiac thrombus.
  • The fragmented thrombus embolized, occluding a coronary artery and leading to MI.

Implications:

  • Embolic myocardial infarction is a rare but severe complication of rtPA therapy.
  • This case underscores the potential risks of systemic thrombolysis in patients with underlying cardiac conditions.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
468
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
466
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
665
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.7K